Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. [Phase 4]
Phase 4 trial update on culture-guided antimicrobial prophylaxis in men undergoing prostate biopsy, focusing on infection-related outcomes a…
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy [Phase 1, Phase 2]
Open-label Phase I/Randomized, Double-Blind Phase II study evaluating AZD5363 in combination with DP chemotherapy for metastatic castration-…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the biodistribution and dosimetry of Ga-68 P16-093 in prostate cancer (recurrent and broader pr…
-
CLINICAL_TRIALS research · 2022-04-29Clinical Trial Update: Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients [Phase 1, Phase 2]
A clinical trial update on radio-guided lymph node dissection for oligometastatic prostate cancer, encompassing Phase 1 and Phase 2 stages.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer [Phase 2]
Phase 2 trial comparing enzalutamide to standard androgen deprivation therapy in hormone-sensitive prostate cancer has completed and posted …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for sEphB4-HSA in metastatic castration-resistant prostate cancer; status not clearly specified and results po…
-
FDA approval · 2022-04-26FDA Approved: ERLEADA — Supplemental Application (Janssen Products, LP)
The FDA approved a supplemental application for ERLEADA (apalutamide) filed by Janssen Products, LP.
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating hyperpolarized C-13 pyruvate as a biomarker in advanced solid tumor malignancies, with prostate cance…
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel [Phase 2, Phase 3]
A completed Phase 2/3 trial update evaluating the optimal sequencing of treatments for poor-risk metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide [Phase 2]
Phase 2 clinical trial evaluating PET/CT and WB MRI for staging and response in metastatic prostate cancer patients receiving enzalutamide h…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide [Phase 2]
Phase 2 trial update exploring imaging staging and response prediction in metastatic hormone-sensitive prostate cancer patients treated with…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating hormone therapy in combination with intensity-modulated radiation therapy for metastatic prostate cancer, with resu…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Maintaining Suppression of Testosterone With Transdermal Estradiol Gel [Phase 2]
Phase 2 trial update on maintaining suppression of testosterone with transdermal estradiol gel in prostate cancer; study terminated with pos…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. [Phase 4]
A Phase 4 clinical trial evaluating switching from Zoladex monthly or quarterly to Eligard semiannual in men with prostate cancer has comple…
-
CLINICAL_TRIALS withdrawal · 2022-03-29Clinical Trial Update: Trial of NanoPac Focal Therapy for Prostate Cancer [Phase 2]
A Phase 2 trial of NanoPac focal therapy for prostate cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-29Clinical Trial Update: Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patients [Phase 2]
Phase 2 trial evaluating bicalutamide with or without metformin for biochemical recurrence in overweight/obese prostate cancer patients; stu…
-
CLINICAL_TRIALS trial_result · 2022-03-25Clinical Trial Update: Cabozantinib and Androgen Ablation in Patients With Androgen-Dependent Metastatic Prostate Cancer [Phase 2]
Phase 2 clinical trial evaluating cabozantinib with androgen ablation in androgen-dependent metastatic prostate cancer completed with posted…
-
FDA approval · 2022-03-24FDA Approved: YONSA — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical's supplemental application for YONSA (abiraterone acetate), a prostate cancer therapy. The approval authoriz…
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial of stereotactic body radiation therapy for prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-23Clinical Trial Update: Comparative Analysis of Transperineal Versus Transrectal Approaches for MRI-Targeted Biopsy of the Prostate for the Detection and Characterization of Prostate Cancer [NA]
A terminated clinical trial comparing transperineal and transrectal MRI-targeted biopsy for prostate cancer detection and characterization, …
-
CLINICAL_TRIALS trial_result · 2022-03-18Clinical Trial Update: 64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer [Phase 1, Phase 2]
Clinical trial update for 64Cu-SAR-bisPSMA PET imaging in prostate cancer across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating enhanced systemic therapy combined with local treatment for primary and metastatic lesions in oligometastatic prost…
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer [Phase 2]
Phase 2 trial of multi-epitope TARP peptide autologous dendritic cell vaccination in men with stage D0 prostate cancer (terminated; results …
-
CLINICAL_TRIALS trial_result · 2022-03-08Clinical Trial Update: An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma [Phase 2]
Phase II open-label study evaluating biweekly docetaxel with androgen-deprivation therapy in previously untreated metastatic prostate cancer…
-
CLINICAL_TRIALS trial_result · 2022-03-02Clinical Trial Update: The Study of Olaparib in Newly Diagnosed mCRPC Patients With HRR Gene Mutation [Phase 2]
Phase 2 study evaluating olaparib in newly diagnosed metastatic castration-resistant prostate cancer patients with HRR gene mutations.